Literature DB >> 3702505

Aggressive or non-aggressive tumor therapy.

P Reizenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3702505     DOI： 10.1007/bf02934568

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN： 0736-0118


× No keyword cloud information.
  14 in total

1.  Physiological adaptation in the development of aminopterin-resistance.

Authors:  P G REIZENSTEIN
Journal:  Acta Haematol       Date:  1961-03       Impact factor: 2.195

2.  Lack of correlation between blast cell size and length of first remission in acute lymphocytic leukemia in childhood.

Authors:  V M Wagner; R L Baehner
Journal:  Med Pediatr Oncol       Date:  1977

Review 3.  Advances in the treatment of acute myelogenous leukemia.

Authors:  R P Gale
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

4.  Cellularity and cell proliferation rates in human bone marrow. 3. Sudies on bone marrow cellularity and erythrokinetics in primary and secondary polycythaemia.

Authors:  K O Skårberg; R Cea; P Reizenstein
Journal:  Acta Med Scand       Date:  1974-04

5.  Karyotypic conversion in Ph1-positive chronic myeloid leukaemia with combination chemotherapy.

Authors:  J C Sharp; M V Joyner; A W Wayne; J Kemp; M Crofts; A D Birch; G McArthur; S Lai; H Sterndale; Y Williams
Journal:  Lancet       Date:  1979-06-30       Impact factor: 79.321

Review 6.  [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].

Authors:  G Mathé; J L Misset; D Machover; L Schwarzenberg; M Timus; C Jasmin; P Ribaud; M Musset
Journal:  Biomed Pharmacother       Date:  1984       Impact factor: 6.529

7.  Lack of correlation of lymphoblast cell size with presence of T-cell markers or with outcome in childhood acute lymphoblastic leukaemia.

Authors:  S B Murphy; L Borella; L Sen; A Mauer
Journal:  Br J Haematol       Date:  1975-09       Impact factor: 6.998

8.  Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients.

Authors:  M Beksac; C Peterson; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer.

Authors:  T J Powles; R C Coombes; I E Smith; J M Jones; H T Ford; J C Gazet
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

10.  A phase II study of alternating combination chemotherapy in 55 myeloma patients. A comparison with non-alternating combination chemotherapy and treatment with a single cytostatic.

Authors:  E Osby; P Reizenstein; G Mathé; M Peetermans; C M Blanc; C Cauchie; D Fiere; M Jaubert
Journal:  Anticancer Res       Date:  1985 Jul-Aug       Impact factor: 2.480
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.